All In Biotech

Drug Trial Radar · NCT06235775

Administration of GV1001 for the Treatment of Progressive Supranuclear Palsy Who Completed Study GV1001-PSP-CL2-011

Twelve-months Extension Study to Explore the Long-Term Safety and Efficacy of Subcutaneous Administration of GV1001 1.12 mg/Day in Patients With Progressive Supranuclear Palsy Who Completed Study GV1001-PSP-CL2-011

Last checked: Nov 19, 2026Latest source record: Nov 21, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

67

Actual

Start

Dec 12, 2023

Primary completion

Sep 1, 2025

Study completion Sep 1, 2025

Sponsor

Lead sponsor
GemVax & KaelIndustry
Sponsor type
Industry
First posted
Feb 1, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 41 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study will be conducted by the Sponsor to evaluate Twelve-months Long-Term Safety and Efficacy of GV1001 (1.12 mg) administered subcutaneously as a treatment for Progressive Supranuclear Palsy(PSP). In 75 patients diagnosed with PSP Richardson(PSP-RS) or PSP-Parkinsonism (PSP-P) who Completed Study GV1001-PSP-CL2-011.

Conditions

  • Progressive Supranuclear Palsy

Interventions

  • GV1001 PlaceboDrug

    0.9% normal saline

  • GV1001 1.12mgDrug

    Lyophilized peptide from hTERT

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Adverse EventTime frame: 12 months
  2. Change in Hematological tests WBC(10^3/µl)Time frame: 12 months
  3. Change in Hematological tests RBC(10^6/µl)Time frame: 12 months
  4. Change in Hematological tests Hemoglobin(g/dL)Time frame: 12 months
  5. Change in Hematological tests Hematocrit(%)Time frame: 12 months
  6. Change in Hematological tests Platelets count(10^3/µl)Time frame: 12 months
  7. Change in Hematological tests WBC differential count (Neutrophils(%))Time frame: 12 months
  8. Change in Hematological tests WBC differential count( Lymphocytes(%))Time frame: 12 months
  9. Change in Hematological tests WBC differential count( Monocytes(%))Time frame: 12 months
  10. Change in Hematological tests WBC differential count(Eosinophils(%))Time frame: 12 months
  11. Change in Hematological tests WBC differential count(Basophils(%))Time frame: 12 months
  12. Change in Hematochemical tests BUN(mg/dL)Time frame: 12 months
  13. Change in Hematochemical tests Creatinine(mg/dL)Time frame: 12 months
  14. Change in Hematochemical tests Uric acid(mg/dL)Time frame: 12 months
  15. Change in Hematochemical tests Total bilirubin(mg/dL)Time frame: 12 months
  16. Change in Hematochemical tests Albumin(g/dL)Time frame: 12 months
  17. Change in Hematochemical tests Total Protein(g/dL)Time frame: 12 months
  18. Change in Hematochemical tests ALT(U/L)Time frame: 12 months
  19. Change in Hematochemical tests AST(U/L)Time frame: 12 months
  20. Change in Hematochemical tests γ-GTP(U/L)Time frame: 12 months
  21. Change in Hematochemical tests Alkaline phosphatase(U/L)Time frame: 12 months
  22. Change in Hematochemical tests Glucose(mg/dL)Time frame: 12 months
  23. Change in Hematochemical tests Total Cholesterol(mg/dL)Time frame: 12 months
  24. Change in urine tests Protein-Albumin(mg/dL)Time frame: 12 months
  25. Change in urine tests Glucose(mg/dL)Time frame: 12 months
  26. Change in urine tests Ketones(mg/dL)Time frame: 12 months
  27. Change in urine tests WBC(HPF)Time frame: 12 months
  28. Change in urine tests Blood-RBC(HPF)Time frame: 12 months
  29. Blood Pressure (mmHG)Time frame: 12 months
  30. Pulse rate(beats per min)Time frame: 12 months
  31. Respiratory rate(breaths per min)Time frame: 12 months
  32. temperature(℃)Time frame: 12 months
  33. EKGTime frame: 12 months

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • Seoul National University Bundang Hospital

    Seongnam-si, South Korea

  • Kyung Hee University Hospital

    Seoul, South Korea

  • Samsung Medical Center

    Seoul, South Korea

  • Seoul Metropolitan Government Seoul National University Boramae Medical Center

    Seoul, South Korea

  • Seoul National University Hospital

    Seoul, South Korea

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.